What are the side effects of Sermorelin & GHRP-6 & GHRP-2 Triple Blend?

Side effects documented in research include: Higher cortisol and prolactin elevation than dual blends; Pronounced appetite stimulation; Greater water retention potential; Injection site reactions. For educational reference only.

Peptide Blends

Sermorelin & GHRP-6 & GHRP-2 Triple Blend

A triple-peptide research blend combining sermorelin, GHRP-6, and GHRP-2 for maximal GH pathway stimulation across multiple receptor targets.

Multiple componentsHalf-life: Sermorelin: ~20 min; GHRP-6: ~1.5 h; GHRP-2: ~1 h

Community Rating

No ratings yet

Compound Profile

Sermorelin & GHRP-6 & GHRP-2 Triple Blend

Key Data

FormulaMultiple components

Half-lifeSermorelin: ~20 min; GHRP-6: ~1.5 h; GHRP-2: ~1 h

CategoryPeptide Blends

Research reference only

Research Focus

Triple receptor mechanism for maximum GH axis stimulation

Dual GHRP compounds for amplified somatostatin suppression

Enhanced IGF-1 response vs dual-peptide combinations

Preclinical data

⚠ Research & Educational Use Only. Sermorelin & GHRP-6 & GHRP-2 Triple Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.

Chemistry review: Ashish KumarWritten by the KnowYourPeptide Research TeamLast updated July 2026

Our editorial standards →

Key Takeaways

Triple receptor mechanism for maximum GH axis stimulation
Dual GHRP compounds for amplified somatostatin suppression
Enhanced IGF-1 response vs dual-peptide combinations
Sermorelin & GHRP-6 & GHRP-2 Triple Blend is not FDA-approved for human use. It is a research chemical for scientific study only.

Research At a Glance

Triple receptor mechanism for maximum GH axis stimulation
Dual GHRP compounds for amplified somatostatin suppression
Enhanced IGF-1 response vs dual-peptide combinations
Appetite stimulation from GHRP-6 component

Calculate Sermorelin & GHRP-6 & GHRP-2 Triple Blend dose

Who researches this:Researchers studying maximum GH secretagogue protocols with triple-compound stackingThose investigating whether dual GHRP combinations with GHRH provide advantages over single GHRP pairsPeople studying the combined cortisol/prolactin/GH endocrine response to GHRH + dual GHRPScientists researching the ceiling effects of GH secretagogue combinations

💡

In Plain English

Simple summary

The Sermorelin + GHRP-6 + GHRP-2 triple combination is a high-intensity GH secretagogue protocol stacking GHRH with two different GHRPs simultaneously. The rationale is that GHRP-6 and GHRP-2 may have slightly different subpopulation effects at ghrelin receptors and somatostatin-modifying activity, and that the combination of two GHRPs alongside GHRH provides broader somatotropic stimulation. In practice, this combination produces very high GH pulses but with correspondingly greater cortisol, prolactin, and appetite effects from the dual GHRP stimulation. It's used in research contexts where maximum GH output is prioritized over endocrine selectivity.

Triple receptor mechanism for maximum GH axis stimulation
Dual GHRP compounds for amplified somatostatin suppression
Enhanced IGF-1 response vs dual-peptide combinations

The full scientific detail, mechanisms, citations, and dosing data, follows below.

What is Sermorelin & GHRP-6 & GHRP-2 Triple Blend?

Tap any underlined term for an instant definition.

The Sermorelin & GHRP-6 & GHRP-2 Triple Blend represents a three-component GH-stimulating research preparation. By combining a GHRH analogue (sermorelin) with two different GHSPs (GHRP-6 and GHRP-2), this blend engages the GH axis through multiple overlapping mechanisms, producing GH responses that exceed dual-peptide combinations in some protocols.

What It Is

Sermorelin: GHRHR agonist (GHRH pathway)
GHRP-2: GHS-R1a agonist (pure GH secretagogue, some cortisol/prolactin)
GHRP-6: GHS-R1a + motilin receptor agonist (GH + appetite stimulation)
Triple combination for maximum somatotroph stimulation

How It Works

All three peptides simultaneously engage the GH axis via distinct receptor populations
GHRP-6 and GHRP-2 together produce additive somatostatin suppression and GH release above either GHRP alone
Sermorelin adds direct GHRHR activation on top of the dual GHRP effect
Maximum GH pulse amplitude reported in triple-component studies is 4-6x either single peptide alone

Key Research Findings

GH amplitude: Triple combination produces highest GH peaks among non-GHRH direct injection protocols
IGF-1: Sustained elevation of 70-90% above baseline with daily triple combination
Side effects: Cortisol and prolactin elevation are more pronounced than dual-GHRP protocols; dose reduction of individual GHRPs recommended

Dosing From the Literature

Sermorelin 100-200 mcg + GHRP-6 100 mcg + GHRP-2 100 mcg per injection
Lower individual doses prevent excessive cortisol/prolactin elevation
Once daily at bedtime

Storage and Handling

Lyophilised: 2-8 degrees C; 24 months
Reconstituted: 2-8 degrees C; use within 30 days

By the Numbers

Triple compound stack

GHRH receptor + ghrelin receptor (two ligands simultaneously) -- maximum simultaneous GH axis stimulation

High cortisol and appetite effects

Dual GHRP stimulation amplifies cortisol elevation and appetite stimulation beyond any single GHRP combination

Near-ceiling GH pulse

Produces near-maximal GH response -- there are physiological limits to GH pulse amplitude that this combination approaches

Key Research Benefits

Documented effects observed in preclinical and clinical studies on Sermorelin & GHRP-6 & GHRP-2 Triple Blend. See all Peptide Blends peptides for comparison.

Triple receptor mechanism for maximum GH axis stimulation

Dual GHRP compounds for amplified somatostatin suppression

Enhanced IGF-1 response vs dual-peptide combinations

Appetite stimulation from GHRP-6 component

Side Effects & Risks

Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →

Dosing Data from the Literature

Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.

Research Dosing Protocol

Typical: sermorelin 100-200 mcg + GHRP-6 100 mcg + GHRP-2 100 mcg per administration.

Enter your vial size and target dose to get the exact injection volume.

Administration in Research Settings

Standard reconstitution and administration methodology for laboratory research use.

Subcutaneous injection. Reduce individual GHRP doses relative to single-GHRP protocols to manage side effects.

What the research doesn't show

Stacking two GHRPs together with GHRH amplifies all effects -- GH, cortisol, prolactin, and appetite. This combination is at the aggressive end of GH secretagogue research protocols. Whether the additional GH pulse magnitude from dual GHRP vs single GHRP provides proportionate research benefits over the additional side effect burden is not established by clinical data.

Medical Expert Videos

Physicians, researchers, and pharmacologists explain Sermorelin & GHRP-6 & GHRP-2 Triple Blend, covering mechanisms of action, clinical context, and study findings.

YouTube, Sermorelin & GHRP-6 & GHRP-2 Triple Blend · doctors & researchersOpen in YouTube

Videos sourced from YouTube search. KnowYourPeptide does not endorse any individual creator. For research education only.

📋

The Bottom Line

Sermorelin & GHRP-6 & GHRP-2 Triple Blend has a growing body of preclinical evidence and a well-characterised safety profile in research settings. The most-studied application is: triple receptor mechanism for maximum gh axis stimulation.

The most commonly reported side effect in research subjects is higher cortisol and prolactin elevation than dual blends. It is a research chemical, not approved for human use.

Research chemicalNot for human useEducational purposes only

Frequently Asked Questions

Explore Further

All Peptide Blends research peptides Full research peptide directory Sermorelin & GHRP-6 & GHRP-2 Triple Blend dose calculator Compare Sermorelin & GHRP-6 & GHRP-2 Triple Blend with other peptides Browse all research categories Full site index

Quick Reference

More in Peptide Blends

View all in category

How It Compares

CJC-1295 + Ipamorelin achieves sustained high-level GH with better endocrine selectivity. For the purely research goal of producing maximum GH secretagogue responses, this triple combination approaches the theoretical ceiling. For any practical purpose where side effects matter, the dual combination (sermorelin + one GHRP) with ipamorelin as the GHRP partner is more suitable.

Compare Sermorelin & GHRP-6 & GHRP-2 Triple Blend side-by-side

Research Use Only

This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.